This manual describes brief intervention and therapy techniques for the treatment of alcohol and drug misuse.

These guidelines are for clinicians who lead group therapy sessions for substance use disorder treatment. It describes types of group therapy, and advantages of group therapy. The guide also provides client placement criteria, and techniques for group development and leadership.

This guide provides clinicians with treatment, screening, and intervention tools to address the needs of men in recovery.

This manual serves as a quick reference guide for clinicians treating chronic pain in adults living with a history of substance use. It covers patient assessment and treatment, and provides an algorithm for managing chronic pain, as well as a summary of non-opioid analgesics.

This quick guide helps clinicians and other service providers address suicide and suicide prevention in patients living with substance use disorders. It covers risk factors and warning signs for suicide, core competencies, and information for administrators and clinical supervisors.

This guide informs clinicians about medications for opioid use disorder treatment, including side effects, drug interactions, and take-home doses. It discusses patient counseling, associated medical issues, hepatitis C evaluation, drug testing, and pregnant women.

This kit provides tools to assist in developing mental health programs that help prevent or reduce severe aggressive behavioral, emotional, and development issues in children by enhancing the knowledge of parents, caregivers, and providers. It includes six booklets.

This manual provides physicians with quick reference information about three FDA-approved medications to help patients achieve abstinence from alcohol: acamprosate, disulfiram, and naltrexone (oral and extended-release). It also includes patient management tips.

This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone.

This manual provides substance use disorder treatment providers with guidelines for addressing treatment issues in various settings within the criminal justice system. It discusses screening and assessment, triage and placement, and treatment issues for specific populations.